Register for: Changes to the review format with study centric data and a focused review article: What does it mean for authors?
Changes to the review format with study centric data and a focused review article: What does it mean for authors?
Duration:
60 minutes
60 minutes
Agenda:
Cochrane was founded in 1993 and has grown into a global network producing gold standard evidence syntheses. Over those years we’ve been doing things in the same way and during that time the field has evolved. To maintain our place as one of the world’s leaders in producing trusted evidence, we are making some big changes in 2023.
Reviews will be shorter. Users of evidence are best served by a more focused article, which also makes writing and updating them simpler. The main body of the review will contain sections that are most useful to users of Cochrane evidence, with a clearer distinction between the main article and supplementary materials.
With a shorter review we are moving the structure to where it’s needed most: the data. This change is powered by moving to study centric data in RevMan. By improving the structure of data associated with Cochrane reviews, we can increase their impact by making it easier for policy makers, guideline developers and others to reuse our evidence.
In this webinar, Ella Flemyng (Interim Head of Editorial Policy and Research Integrity) and Gert van Valkenhoef (Head of IT Infrastructure and Development) will discuss the benefits of these developments and what guidance and support is available.
Log in to registerCochrane was founded in 1993 and has grown into a global network producing gold standard evidence syntheses. Over those years we’ve been doing things in the same way and during that time the field has evolved. To maintain our place as one of the world’s leaders in producing trusted evidence, we are making some big changes in 2023.
Reviews will be shorter. Users of evidence are best served by a more focused article, which also makes writing and updating them simpler. The main body of the review will contain sections that are most useful to users of Cochrane evidence, with a clearer distinction between the main article and supplementary materials.
With a shorter review we are moving the structure to where it’s needed most: the data. This change is powered by moving to study centric data in RevMan. By improving the structure of data associated with Cochrane reviews, we can increase their impact by making it easier for policy makers, guideline developers and others to reuse our evidence.
In this webinar, Ella Flemyng (Interim Head of Editorial Policy and Research Integrity) and Gert van Valkenhoef (Head of IT Infrastructure and Development) will discuss the benefits of these developments and what guidance and support is available.
Share